Diagnosis, prevention and treatment of postoperative Crohn's disease recurrence

Digestive and Liver Disease

Volumn 44, Issue 6, 2012, Pages 453-460

  Buisson, Anthony ^a,b   Chevaux, Jean Baptiste ^c   Bommelaer, Gilles ^a,b   Peyrin Biroulet, Laurent ^c  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Crohn's disease; Diagnosis; Postoperative recurrence; Prevention; Treatment

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; BUDESONIDE; CALGRANULIN; ENEMA; INFLIXIMAB; INTERLEUKIN 10; LACTOFERRIN; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METRONIDAZOLE; ORNIDAZOLE; PROBIOTIC AGENT; SALAZOSULFAPYRIDINE;

CAPSULE ENDOSCOPY; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; DIAGNOSTIC ACCURACY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG WITHDRAWAL; ECHOGRAPHY; ENTERIC FEEDING; GOLD STANDARD; HUMAN; META ANALYSIS (TOPIC); NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; REVIEW; SENSITIVITY AND SPECIFICITY; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; AZATHIOPRINE; BIOLOGICAL MARKERS; CAPSULE ENDOSCOPY; COLONOSCOPY; CROHN DISEASE; ENTERAL NUTRITION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MAGNETIC RESONANCE IMAGING; MESALAMINE; RECURRENCE; SULFASALAZINE; TOMOGRAPHY, X-RAY COMPUTED; TUMOR NECROSIS FACTOR-ALPHA; ULTRASONOGRAPHY;

EID: 84860259832     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2011.12.018     Document Type: Review

References (71)

1. Peyrin-Biroulet L., Loftus E.V., Colombel J.-F., et al. The natural history of adult Crohn's disease in population-based cohorts. Am J Gastroenterol 2010, 105:289-297.
2. Regueiro M., Kip K.E., Schraut W., et al. Crohn's disease activity index does not correlate with endoscopic recurrence one year after ileocolonic resection. Inflamm Bowel Dis 2011, 17:118-126.
3. Van Assche G., Dignass A., Reinisch W., et al. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: special situations. J Crohns Colitis 2010, 4:63-101.
4. Olaison G., Smedh K., Sjödahl R. Natural course of Crohn's disease after ileocolic resection: endoscopically visualised ileal ulcers preceding symptoms. Gut 1992, 33:331-335.
5. Rutgeerts P., Geboes K., Vantrappen G., et al. Predictability of the postoperative course of Crohn's disease. Gastroenterology 1990, 99:956-963.
6. Bourreille A., Jarry M., D'Halluin P.N., et al. Wireless capsule endoscopy versus ileocolonoscopy for the diagnosis of postoperative recurrence of Crohn's disease: a prospective study. Gut 2006, 55:978-983.
7. Pons Beltrán V., Nos P., Bastida G., et al. Evaluation of postsurgical recurrence in Crohn's disease: a new indication for capsule endoscopy?. Gastrointest Endosc 2007, 66:533-540.
8. Biancone L., Calabrese E., Petruzziello C., et al. Wireless capsule endoscopy and small intestine contrast ultrasonography in recurrence of Crohn's disease. Inflamm Bowel Dis 2007, 13:1256-1265.
9. Katz J.A. Postoperative endoscopic surveillance in Crohn's disease: bottom up or top down?. Gastrointest Endosc 2007, 66:541-543.
10. Flamant M., Trang C., Bourreille A. Wireless capsule in inflammatory bowel disease. Gastroenterol Clin Biol 2009, 33(Suppl. 3):S183-S189.
11. Andreoli A., Cerro P., Falasco G., et al. Role of ultrasonography in the diagnosis of postsurgical recurrence of Crohn's disease. Am J Gastroenterol 1998, 93:1117-1121.
12. Castiglione F., Bucci L., Pesce G., et al. Oral contrast-enhanced sonography for the diagnosis and grading of postsurgical recurrence of Crohn's disease. Inflamm Bowel Dis 2008, 14:1240-1245.
13. Onali S., Calabrese E., Petruzziello C., et al. Endoscopic vs ultrasonographic findings related to Crohn's disease recurrence: a prospective longitudinal study at 3 years. J Crohns Colitis 2010, 4:319-328.
14. Pallotta N., Giovannone M., Pezzotti P., et al. Ultrasonographic detection and assessment of the severity of Crohn's disease recurrence after ileal resection. BMC Gastroenterol 2010, 10:69.
15. Rispo A., Bucci L., Pesce G., et al. Bowel sonography for the diagnosis and grading of postsurgical recurrence of Crohn's disease. Inflamm Bowel Dis 2006, 12:486-490.
16. Calabrese E., Petruzziello C., Onali S., et al. Severity of postoperative recurrence in Crohn's disease: correlation between endoscopic and sonographic findings. Inflamm Bowel Dis 2009, 15:1635-1642.
17. Soyer P., Boudiaf M., Sirol M., et al. Suspected anastomotic recurrence of Crohn disease after ileocolic resection: evaluation with CT enteroclysis. Radiology 2010, 254:755-764.
18. Sailer J., Peloschek P., Reinisch W., et al. Anastomotic recurrence of Crohn's disease after ileocolic resection: comparison of MR enteroclysis with endoscopy. Eur Radiol 2008, 18:2512-2521.
19. Koilakou S., Sailer J., Peloschek P., et al. Endoscopy and MR enteroclysis: equivalent tools in predicting clinical recurrence in patients with Crohn's disease after ileocolic resection. Inflamm Bowel Dis 2010, 16:198-203.
20. Lamb C.A., Mohiuddin M.K., Gicquel J., et al. Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn's disease. Br J Surg 2009, 96:663-674.
21. Orlando A., Modesto I., Castiglione F., et al. The role of calprotectin in predicting endoscopic post-surgical recurrence in asymptomatic Crohn's disease: a comparison with ultrasound. Eur Rev Med Pharmacol Sci 2006, 10:17-22.
22. Scarpa M., D'Incà R., Basso D., et al. Fecal lactoferrin and calprotectin after ileocolonic resection for Crohn's disease. Dis Colon Rectum 2007, 50:861-869.
23. Daperno M., D'Haens G., Van Assche G., et al. Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD. Gastrointest Endosc 2004, 60:505-512.
24. Schoepfer A.M., Beglinger C., Straumann A., et al. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI. Am J Gastroenterol 2010, 105:162-169.
25. Caprilli R., Andreoli A., Capurso L., et al. Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Aliment Pharmacol Ther 1994, 8:35-43.
26. McLeod R.S., Wolff B.G., Steinhart A.H., et al. Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease. Gastroenterology 1995, 109:404-413.
27. Brignola C., Cottone M., Pera A., et al. Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Italian Cooperative Study Group. Gastroenterology 1995, 108:345-349.
28. Lochs H., Mayer M., Fleig W.E., et al. Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI. Gastroenterology 2000, 118:264-273.
29. Florent C., Cortot A., Quandale P., et al. Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID). Eur J Gastroenterol Hepatol 1996, 8:229-233.
30. Hanauer S.B., Korelitz B.I., Rutgeerts P., et al. Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. Gastroenterology 2004, 127:723-729.
31. Caprilli R., Cottone M., Tonelli F., et al. Two mesalazine regimens in the prevention of the post-operative recurrence of Crohn's disease: a pragmatic, double-blind, randomized controlled trial. Aliment Pharmacol Ther 2003, 17:517-523.
32. Doherty G., Bennett G., Patil S., et al. Interventions for prevention of post-operative recurrence of Crohn's disease. Cochrane Database Syst Rev 2009, CD006873.
33. Ford A.C., Kane S.V., Khan K.J., et al. Efficacy of 5-aminosalicylates in Crohn's disease: systematic review and meta-analysis. Am J Gastroenterol 2011, 106:617-629.
34. Ewe K., Herfarth C., Malchow H., et al. Postoperative recurrence of Crohn's disease in relation to radicality of operation and sulfasalazine prophylaxis: a multicenter trial. Digestion 1989, 42:224-232.
35. Lennard-Jones J.E. Sulphasalazine in asymptomatic Crohn's disease. A multicentre trial. Gut 1977, 18:69-72.
36. Wenckert A., Kristensen M., Eklund A.E., et al. The long-term prophylactic effect of salazosulphapyridine (Salazopyrin) in primarily resected patients with Crohn's disease. A controlled double-blind trial. Scand J Gastroenterol 1978, 13:161-167.
37. Sutherland L.R., Martin F., Bailey R.J., et al. A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group. Gastroenterology 1997, 112:1069-1077.
38. Hellers G., Cortot A., Jewell D., et al. Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study Group. Gastroenterology 1999, 116:294-300.
39. Ewe K., Böttger T., Buhr H.J., et al. Low-dose budesonide treatment for prevention of postoperative recurrence of Crohn's disease: a multicentre randomized placebo-controlled trial. German Budesonide Study Group. Eur J Gastroenterol Hepatol 1999, 11:277-282.
40. Bergman L., Krause U. Postoperative treatment with corticosteroids and salazosulphapyridine (Salazopyrin) after radical resection for Crohn's disease. Scand J Gastroenterol 1976, 11:651-656.
41. Prantera C., Scribano M.L., Falasco G., et al. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG. Gut 2002, 51:405-409.
42. Marteau P., Lémann M., Seksik P., et al. Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial. Gut 2006, 55:842-847.
43. Van Gossum A., Dewit O., Louis E., et al. Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after lleo-caecal resection. Inflamm Bowel Dis 2007, 13:135-142.
44. Chermesh I., Tamir A., Reshef R., et al. Failure of Synbiotic 2000 to prevent postoperative recurrence of Crohn's disease. Dig Dis Sci 2007, 52:385-389.
45. Madsen K., Backer J.L., Leddin D., et al. M1207 A randomized controlled trial of VSL#3 for the prevention of endoscopic recurrence following surgery for Crohn's disease. Gastroenterology 2008, 134:A-361.
46. Doherty G.A., Bennett G.C., Cheifetz A.S., et al. Meta-analysis: targeting the intestinal microbiota in prophylaxis for post-operative Crohn's disease. Aliment Pharmacol Ther 2010, 31:802-809.
47. Rutgeerts P., Hiele M., Geboes K., et al. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 1995, 108:1617-1621.
48. Rutgeerts P., Van Assche G., Vermeire S., et al. Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial. Gastroenterology 2005, 128:856-861.
49. Nos P., Hinojosa J., Aguilera V., et al. Azathioprine and 5-ASA in the prevention of postoperative recurrence of Crohn's disease. Gastroenterol Hepatol 2000, 23:374-378.
50. Domènech E., Mañosa M., Bernal I., et al. Impact of azathioprine on the prevention of postoperative Crohn's disease recurrence: results of a prospective, observational, long-term follow-up study. Inflamm Bowel Dis 2008, 14:508-513.
51. Myrelid P., Svärm S., Andersson P., et al. Azathioprine as a postoperative prophylaxis reduces symptoms in aggressive Crohn's disease. Scand J Gastroenterol 2006, 41:1190-1195.
52. Cuillerier E., Lémann M., Bouhnik Y., et al. Azathioprine for prevention of postoperative recurrence in Crohn's disease: a retrospective study. Eur J Gastroenterol Hepatol 2001, 13:1291-1296.
53. Papay P., Reinisch W., Ho E., et al. The impact of thiopurines on the risk of surgical recurrence in patients with Crohn's disease after first intestinal surgery. Am J Gastroenterol 2010, 105:1158-1164.
54. D'Haens G.R., Vermeire S., Van Assche G., et al. Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: a controlled randomized trial. Gastroenterology 2008, 135:1123-1129.
55. Ardizzone S., Maconi G., Sampietro G.M., et al. Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease. Gastroenterology 2004, 127:730-740.
56. Peyrin-Biroulet L., Deltenre P., Ardizzone S., et al. Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis. Am J Gastroenterol 2009, 104:2089-2096.
57. Sorrentino D., Paviotti A., Terrosu G., et al. Low-dose maintenance therapy with infliximab prevents postsurgical recurrence of Crohn's disease. Clin Gastroenterol Hepatol 2010, 8:591-599.
58. Sorrentino D., Terrosu G., Avellini C., et al. Infliximab with low-dose methotrexate for prevention of postsurgical recurrence of ileocolonic Crohn disease. Arch Intern Med 2007, 167:1804-1807.
59. Yoshida K., Fukunaga K., Ikeuchi H., et al. W1285 Infliximab mono-therapy prevented post operative recurrence of Crohn's disease after intestinal resection: a prospective randomized open trial in Japanese population. Gastroenterology 2010, 138:S-691.
60. Tarekegn S., Oimoen K., Zadvornova Y., et al. Biologics are superior to immunomodulators in prevention of post-operative recurrence of Crohn's disease. Gastroenterology 2011, 140:S-592.
61. Regueiro M., Schraut W., Baidoo L., et al. Infliximab prevents Crohn's disease recurrence after ileal resection. Gastroenterology 2009, 136:441-450.
62. Regueiro M., Kip K.E., Schraut W.H., et al. W1298 4.5 yr follow-up of patients enrolled in the randomized controlled trial (RCT) of Infliximab (Inf) for prevention of postoperative Crohn's disease (CD). Gastroenterology 2010, 138:S-694.
63. Fernández-Blanco I., Monturiol J., Martinez B., et al. W1291 Adalimumab in the prevention of postoperative recurrence of Crohn's disease. Gastroenterology 2010, 138:S-692.
64. Mantzaris G.J., Papamichael K., Archavlis E.J., et al. Pilot study of adalimumab for early prevention and/or treatment of post-operative endoscopic recurrence of Crohn's disease. Gastroenterology 2011, 140:S-275.
65. Colombel J.F., Rutgeerts P., Malchow H., et al. Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease. Gut 2001, 49:42-46.
66. Esaki M., Matsumoto T., Hizawa K., et al. Preventive effect of nutritional therapy against postoperative recurrence of Crohn disease, with reference to findings determined by intra-operative enteroscopy. Scand J Gastroenterol 2005, 40:1431-1437.
67. Reinisch W., Angelberger S., Petritsch W., et al. Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial. Gut 2010, 59:752-759.
68. Yamamoto T., Umegae S., Matsumoto K. Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohn's disease: a prospective pilot study. Inflamm Bowel Dis 2009, 15:1460-1466.
69. Peyrin-Biroulet L., Ferrante M., Magro F., et al. Results from the 2nd Scientific Workshop of the ECCO (I): impact of mucosal healing on the course of inflammatory bowel disease. J Crohn's Colitis 2011, 5:477-483.
70. Peyrin-Biroulet L., Oussalah A., Roblin X., et al. The use of azathioprine in Crohn's disease during pregnancy and in the post-operative setting: a worldwide survey of experts. Aliment Pharmacol Ther 2011, 33:707-713.
71. Yamamoto T., Nakahigashi M., Umegae S., et al. Impact of long-term enteral nutrition on clinical and endoscopic recurrence after resection for Crohn's disease: a prospective, non-randomized, parallel, controlled study. Aliment Pharmacol Ther 2007, 25:67-72.